

  • Đời sống
    • Du lịch
    • Ăn chơi
    • Làm vườn
  • Giải trí
  • Giáo dục
  • Kinh doanh
    • Thương mại điện tử
    • Bất động sản
    • Globe Newswire
  • Sức khỏe
    • Dinh dưỡng
    • Làm đẹp
  • Khoa học
  • Công Nghệ
  •  Tài khoản
  • ĐĂNG NHẬP TÀI KHOẢN

    
    Hoặc
  • 


  •  Trang chủ
  •  Mới nhất
  •  TOP 10 
    • TOP 2018
    • TOP 2015
    • TOP 2014
  • Facebook
Unlock Your Trading Edge with Axi at the 2025 Money Expo Mexico 4-02-2025, 18:00
Evs Full Year 2022 Results to be Announced on Friday 17 3-02-2023, 00:39
Atos selected by Lotterywest in Western Australia for a 5-year contract to deliver core infrastructure services 5-10-2023, 06:00
 10-03-2026, 20:00

Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection

Notified -

Globe Newswire10-03-2026, 20:00
 19-05-2025, 23:15

Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo

Notified -

Globe Newswire19-05-2025, 23:15
 20-02-2025, 20:00

Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis

Notified -

Globe Newswire20-02-2025, 20:00
 16-01-2025, 22:05

Boehringer provides update on iclepertin Phase III program in schizophrenia

Notified -

Globe Newswire16-01-2025, 22:05
 4-11-2024, 20:57

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Globe Newswire4-11-2024, 20:57
 1-11-2024, 01:22

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak

Globe Newswire1-11-2024, 01:22
 9-09-2024, 22:45

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients

Globe Newswire9-09-2024, 22:45
 15-07-2024, 21:29

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Globe Newswire15-07-2024, 21:29

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.